A brief review of Radiopharmaceuticals Market

Radiopharmaceuticals are medicinal formulations containing radioisotopes that are found to be harmless for humans and can be safely administered for a therapy or diagnosis. Certain radiotracers (called radiopharmaceuticals), the chemical compounds with one or more atoms replaced by a radioisotope, have been traditionally used for imaging disease states and functional morphology of organs. Unlike other popular imaging modalities such as magnetic resonance imaging (MRI), ultrasonography (US), and computed tomography (CT), imaging procedures that use radiopharmaceuticals can also map metabolic activities and physiological functions, thereby giving more precise and specific information about function or dysfunction of an organ or metabolic activity.

Studying the use of radiotracers for therapeutic purposes had begun immediately after the discovery of radioactivity, however, it was not until cyclotrons became available for the acceleration of particles to fabricate radioisotopes that a significant medical application of radiotracers came into being. Radioiodine, for instance, was introduced in 1946 for treating thyroid cancer, and remains till date the most effective method for the treatment of the condition as well as hyperthyroidism.

Mapping the distribution of a radiopharmaceutical element in a body provides images of organ functions in a non-invasive manner and helps diagnose many common health conditions associated with malfunctioning organs as well as the detection of certain cancers. The extensive use and rising demand for imaging techniques that use radiopharmaceuticals are directly attributable to the enormous development observed in the global market for radiopharmaceuticals and has led to the availability of a huge range of specific radiopharmaceuticals.

Market Scenario

Currently, there are more than 100 radiopharmaceuticals in the global market, which are used for the diagnosis of a variety of diseases and for the therapy of a few, including cancer. Transparency Market Research, a U.S.-based market intelligence firm, states in one of its reports that the global radiopharmaceuticals market will grow at a remarkable CAGR of 18.3% between 2012 and 2018. The report also states that the market, which had a net worth of US$3.8 billion in 2011, will reach US$12.2 billion by 2018. Canada’s prominence in the global radiopharmaceuticals market as the largest exporter of uranium and nuclear technology has led the regional market in North America towards a position of dominance in the global marketplace.

Get a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=213

While the market’s growth prospects are huge, the market faces a number of challenges that make exploitation of these opportunities a bit difficult. Elucidated below are some key challenges that the market for radiopharmaceuticals faces:

Low global production of Radiopharmaceuticals: Unlike the production of conventional pharmaceuticals, the production of radiopharmaceuticals still happens on a relatively small scale across the globe. Implementing the current good manufacturing practices (cGMP) guidelines in radiopharmaceutical manufacture is also a very difficult and expensive process. Ensuring cGMP compliances can especially become a demanding task for small-scale manufacturers.

Complex manufacturing cGMP code compliance: Manufacturing of radiopharmaceuticals involves taking care of a number of aspects prior to, during, and after the manufacturing process. It requires the use of controlled procedures and materials, qualified personnel to look after the entire process, production in designated clean rooms, detailed documentation of the process, application of analytical and validated methods, and the release of the final product by a qualified person.

Troubles and delays in transportation of radioactive substances: Transport of radioactive materials is a highly complex matter. Many troubles and delays, the need for obeying transport regulations, and the denial of shipment by certain transport bodies often affect the final use of imported radiopharmaceuticals. Some countries follow the practice of holding up all the cargo for 24 or 48 hours before loading it on the plane, for security purposes. This also leads to a negative effect on the overall properties of radiopharmaceuticals due to radioactive decay of the substance, especially in radioactive materials of extremely short half lives.

Healthcare Biometrics Market: their impact and future predictions

Security has always remained a vital concern in healthcare sector when it comes to safeguard confidential medical data, records and patients’ privacy. Biometric devices analyze biological data of a user by capturing unique his or her physical human features and use them as a future reference (template) for user’s identification. The basic components of biometric identification systems consist of a scanning device or a reader, software to convert the scanned information into digital form and a database to store the biometric data for comparison with entered biometric data.

A variety of human features such as fingerprint, face, iris, vein, voice, hand and signature seem to reveal several potential attributes for biometric authentication. Use of biometrics with the help of these physical characteristics along with logical or physical access or both together has found a worldwide use in the healthcare sector. However, improper storage of medical data may pose a threat of invasion of the user’s identity and thus challenge patient security. Biometric solutions are facilitates the provision restricted access to rooms or computer network systems from unauthorized access.

Healthcare facilities across the globe are increasingly shifting their focus on implementing biometric security solutions for patient identification and their linking to electronic health records system to the respective patients. Integrity of patient identity, efficient and safe data recording, control on medical frauds and reduction in inventory theft are some of the distinct advantages offered by biometrics. Biometrics provides healthcare professionals and patients to secure their information and keep it confidential by only being released such information to those who have the rightful access to it. Biometrics allows matching of a patient to his records with minimal possibility of errors and avoids mixing up of patient information which can have serious consequence on the health and wellbeing of such patients. Moreover, factors such as culmination of false patient identity, patient protection and reduction of the overburden of medical frauds and security of medical records have urged those in the healthcare industry to opt for biometrics.

Even with the ongoing struggle in the economy, especially in the European and Asian countries, healthcare organizations are investing in biometric technologies in order to increase security, privacy and improve patient safety and thus compensate the huge amount money lost in healthcare frauds. Companies investing heavily in developing automated biometric systems with improved accuracy and response time may gain greater benefits in the near future. Introduction of new products with reduced cost and showcasing advantages and advanced capabilities of biometric security solutions at various conferences, laboratories, trade shows, web casting and electronic newsletters is further boosting the growth of new market competitors.

Request for Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=615

Geographically, North America dominates the global healthcare biometrics market owing to extensive implementation of healthcare fraud controlling systems and enforcement of legislations such as HIPAA (Health Insurance Portability and Accountability Act) in the U.S. Furthermore, majority of the market leaders are domiciled in the U.S. and are aggressively involved in technological advances, eventually introducing new biometric devices and products in the global market. Well established market players are also increasingly pushing their cost effective products in emerging markets coupled with showcasing their cost and safety related advantages thereby increasing their adoption in such regions. Growing acceptance of biometrics in by major medical fields and its verified efficiency in hospitals, clinical laboratories, research labs and other healthcare facilities drives the market for healthcare biometrics in North America.

Moreover, factors such as reduction in healthcare frauds, secured patient privacy and medical records, reduction in fake insurance claims reduction in identification and reimbursement processing, cost containment of the biometric devices and introduction of cheaper products with better accuracy will result in rapid adoption of biometrics security solutions in healthcare sector in the emerging markets. Use of multimodal biometric system, which combines different types of biometric methods, such as combining facial and iris recognition is currently rapidly progressing trend. Biometrics is a promising and a fast growing segment in the field of next generation personal authentication and security systems and is changing the perception and look of healthcare industry.

Oral Contraceptive Pills Market, Research Report, 2015 - 2023

Transparency Market Research (TMR) has recently published a study on the global oral contraceptive pills market and estimated the market to rise at a CAGR of 6.60% during the period from 2015 and 2023. The market is expected to increase from a value of US$13.1 bn in 2014 to US$22.9 bn by the end of the forecast period.The research report is titled “Oral Contraceptive Pills Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023.”

Oral contraceptive pills are used to prevent unintended pregnancies. These pills contain several hormones that prevent ovulation in females. The increasing number of awareness programs organized by various governments and NGOs across the world is driving the demand for oral contraceptive pills significantly in the global arena. In addition to this, the rising age of maternity, together with the adoption of family planning by a number of couples, is likely to facilitate steady growth of this market during the forecast period.

The report studies the global market for contraceptive pills on the basis of the type, category, and regional distribution. Based on the type of oral contraceptive pills, the market has been classified into progestin-only pills, combination pills, and other types of pills.

The combination contraceptive pills segment led the overall market in 2014 and is likely to maintain its dominance over the forecast period. The high efficiency of combination pills is increasing their popularity among consumers, which is likely to drive their demand remarkably in the coming years.

In terms of the category, the market has been segmented into generic oral contraceptive pills and branded oral contraceptive pills. In 2014, the generic contraceptive pills segment dominated the overall market. Analysts project this segment to retain its leadership over the forecast period, owing to the massive demand for generic contraceptive pills, propelled by their declining prices.

Based on the regional distribution of this market, the report categorizes the global oral contraceptive pills market into Asia Pacific, Europe, Latin America, North America, and the Middle East and Africa. North America held the leading position in the overall market in 2014. The rising number of unintended pregnancies in North American countries has fueled the demand for oral contraceptive pills in North America significantly.

Additionally, the increasing awareness pertaining to contraceptives and the advantages they offer in preventing unwanted pregnancies and the implementation of favorable reimbursement regulations are likely to propel the North America market for oral contraceptive pills in the near future.

Download Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=8323

Asia Pacific is anticipated to witness a surge in the demand for oral contraceptive pills and emerge as the most attractive regional market over the next few years. The rising awareness regarding the usage of contraception to prevent unwanted pregnancies is projected to boost the Asia Pacific market for oral contraceptive pills during the forecast period, states the report.

Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mankind Pharma Ltd., Allergan plc (Actavis), Janssen Global Services LLC, Piramal Enterprises Ltd., Merck & Co. Inc., and Bayer AG are some of the major international producers of oral contraceptive pills mentioned in this research study.

Surgical Navigation Systems Market witnesses a year of significant changes

Since the last decade, incidences of trauma are rising globally and therefore number of cases of surgeries is growing swiftly. In addition, increasing geriatric population worldwide is resulting in increased demand for orthopedic replacements mainly, hip replacement, shoulder replacement and knee replacement surgeries. In addition, improving lifestyle, increasing healthcare spending and increased awareness about advancement in the healthcare technologies are some of the factors that are augmenting the growth of the global surgical navigation systems market. Presently, neurosurgical navigation systems market is leading the global surgical navigation systems market. Orthopedic surgical navigation systems market is expected to grow at a faster rate owing to rising geriatric population and thereby rising incidences of hip, knee and shoulder fractures.

Surgical navigation systems include use of imaging modalities during the surgical procedure and thereby enable minimally invasive surgery. Demand for minimally invasive surgeries is increasing globally owing to advantage of minimally invasive surgeries such as rapid wound healing, reduced hospital stay and lesser pain to the patient. Thus, demand for surgical navigation systems is increasing as well. While on the other hand, growth of the surgical navigation systems market is challenged by costly equipment. In addition, surgical navigation systems are not repeatedly purchased by end-users which is resulting in difficulty for existing market players in reaching new customers. Further, in order to sustain the competition and to expand the market share, existing players in the surgical navigation systems are implementing marketing strategies such as offering Continual Medical Education (CME) classes to surgeons and other healthcare professionals. Some of the market players are offering fee per use, customer portal and operating room assistance facilities to customers aiming increasing adoption of surgical navigation systems in the healthcare facilities. Market players in the surgical navigation systems are expected to offer ENT navigation systems at lower price to community hospitals to sustain the market competition by tapping untapped markets.

Get a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2646

Presently, North America is leading the global surgical navigation systems market and is closely followed by Europe. Well defined regulatory framework, exceptionally developed healthcare infrastructure and higher healthcare spending are some of the factors that are contributing to the growth of the surgical navigation systems market in the North American region. Asia-Pacific is a lucrative market for surgical navigation systems. Some of the factors such as increasing healthcare spending, government initiative to improve healthcare infrastructure in Asia-Pacific countries and availability of advanced healthcare facilities on the grounds of rapidly growing medical tourism industry in this region are expected to fuel the growth of the surgical navigation systems market in the region.

Dental Laboratories Market To See Good Times Ahead

Transparency Market Research has published a new market report titled, “Dental Laboratories Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023.” According to the report, the global dental laboratories market was valued at US$ 12,991.6 Mn in 2014 and is projected to expand at a CAGR of 4.9% from 2015 to 2023 to reach US$ 20,234.1 Mn in 2023.

Dental laboratories are an amalgamation of art, science, and technology required for designing and manufacturing of products as a replacement of natural teeth. The scope of the research encompasses development of products such as crowns, bridges, caps, veneers, and other orthodontic splints and appliances essential to protect and straighten teeth. Similar to other areas/domains of the health care industry, the dentistry segment has witnessed significant growth over the past few years. Introduction of novel technologies and innovative materials have also attributed to the evolution of the dental laboratories market.

Geographically, the global dental laboratories market has been segmented into four major regions: North America, Europe, Asia Pacific, and Rest of the World. Each region has been further analyzed and estimated for major contributing countries. For instance, North America includes the U.S. and Canada. Europe has been sub-categorized into the U.K., Germany, France, Spain, Italy, and Rest of Europe. Asia Pacific includes China, Japan, and Rest of Asia Pacific. Rest of the World has been studied and segmented into Latin America and Middle East & Africa.

Europe accounted for the lion’s share of the global dental laboratories market in 2014, followed by North America. A number of community-based oral health programs are conducted across the European Union that focus on delivery of preventive treatment, increase awareness, and enhance patient education toward various procedures and artificial dental products, which over the past few years have contributed to the growth of the dental laboratory industry. However, Asia Pacific is expected to outperform the two major contributing regions during the forecast period from 2015 to 2023. Growth of the market in Asia Pacific is primarily driven by rising trend of dental tourism and increase in the number of laboratories established in the last five years. Moreover, the market is projected to expand at a substantial growth rate due to increase in export demand for dental orthodontic, periodontics, crowns, bridges, and implants from emerging markets such as India and China. Health care provision in Africa is challenged by the burden of poverty and underdevelopment, with 80% of the population falling into the lowest socioeconomic category. Lack of financial and technical resources, shortage of health personnel, and insufficient primary health care delivery make it hard for most of the population of Africa to access basic health services. Shortage of oral health personnel is a common problem in Africa, as the average dentist to population ratio is approximately 1:150000 compared to 1:2000 in most developed economic countries.

Lack of proper reimbursement and high operational cost are the major restraints of the global dental laboratory industry. To operate a dental laboratory, around 40% to 60% of what a dentist pays goes toward the expense of running a modern dental practice. Additionally, pay for rent or mortgage payments on their office space, payroll for hygienists, office managers and receptionists, health insurance, taxes, supplies, business insurance, and technology are the other expense burdens on laboratory owners. High operational cost, intense competition, and restricted geographical reach are among the primary reasons for closure of large number of dental laboratories in the past few years that is common in both developed and emerging markets.

Get a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2320

Advent of CAD/CAM technology has significantly reduced the design and manufacturing time for dental prosthesis such as crowns and bridges. 3D imaging techniques have improved patient diagnosis and procedure planning; hence are considered to be other factors driving sustained growth and demand for dental laboratories and services offered to dentists. Rising costs and declining insurance reimbursements have created high demand for outsourced dental laboratories work. Currently, approximately 40% to 50% dental laboratories in the U.S. use off-shore laboratory services to produce components and/or complete dental laboratory services such as crowns, bridges, single porcelain fused to gold, complete dentures, partials, and frameworks.

Key players operating in this market are 3M Health Care, Danaher Corporation, Dentcare Dental Lab, Henry Schein, Inc., Institut Straumann AG, Keating Dental Arts, Modern Dental Laboratory Co., Ltd., National Dentex Corporation, Patterson Companies, Inc., Shofu, Inc., Sirona Dental Systems, and Yenadent Ltd. Sti.

Hospital Infection Therapeutics Market Trends and Forecast 2014 – 2020

A new market research study, titled “Hospital Infection Therapeutics Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020,” has been published by Transparency Market Research, providing a comprehensive analysis of the market. The major driving factors, barriers, and current trends of the global hospital infection therapeutics market have been included in the scope of the research report.

As per the research study, in 2013, the global market for hospital infection therapeutics was valued at US$3.1 bn and is estimated to reach US$3.6 bn by the end of 2020. The market is predicted to exhibit a 3.10% CAGR between 2014 and 2020.

Hospital-acquired infections are majorly caused by fungal, bacterial, and viral pathogens. Several cases of hospital infections are acquired from the intensive care units of hospitals. A huge number of antimicrobial drugs have demonstrated their capability in treating a wide range of hospital infections. The increasing number of pipeline drug molecules in the hospital infection therapeutics market is one of the biggest opportunities for the growth of the market. In addition, the absence of skilled staff in developing and underdeveloped countries and growing prevalence of several hospital infections are the major factors expected to fuel the growth of the market in the next few years.

Based on the major prominent types of drugs in the market, the global market for hospital infection therapeutics has been segmented into antiviral, antibacterial, and antifungal drugs. In 2013, the antibacterial drugs segment dominated the market, accounting for a 70.7% share in the global market for hospital infection therapeutics. This segment is projected to grow at a fast pace in the next few years. The research study has further analyzed the major drugs in the pipeline, including Plazomicin, Ceftolozane, Delafloxacin, Eravacycline, Surotomycin, Tedizolid, Amikacin Inhale, MK-3415A, CAZ AVI, Dalvance, and Oritavancin.

On the basis of type of infection, the global market for hospital infection therapeutics has been categorized into gastrointestinal disorders, hospital-acquired pneumonia, urinary tract infections, surgical site infections, bloodstream infections, and other infections. In 2013, the hospital-acquired pneumonia segment accounted for a 20% share in the global market for hospital infection therapeutics. Nevertheless, the urinary tract infections segment is anticipated to grow rapidly in the near future.

Request Sample for this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1280

Currently, North America leads the overall market and is estimated to remain in the leading position in the next few years. North America is closely trailed by Europe. The rapid growth of these two regional markets can be attributed to the increasing healthcare awareness and growing demand for advanced drugs. On the other hand, the Asia Pacific market for hospital infection therapeutics is estimated to witness the fastest growth throughout the forecast period.

Furthermore, the research report talks about the competitive scenario of the global market for hospital infection therapeutics. Detailed profiles of the prominent players have been discussed in the scope of the research study. Some of the leading players operating in the market are Bayer AG, Johnson & Johnson Services, Inc., Actavis plc, Sanofi, Bristol-Myers Squibb Company, Merck & Co., Inc., GlaxoSmithKline plc, Pfizer, Inc., AstraZeneca plc, and Cubist Pharmaceuticals, Inc.

Emerging Opportunities in Empty Capsules Market

Global Empty Capsules Market: Overview

The demand for capsules is growing on account of the mounting consumption of medicines worldwide. This trend augurs well for the global empty capsules market, where growth has thus far been driven by the demand for both nongelatin and hard gelatin capsules. The changing demographics of the world have necessitated the greater production of medicines to treat various kinds of diseases. Capsules, being among the most versatile forms of administering drug doses, are thus expected to be consumed in larger volumes over the next few years.

The typical capsule is made from gelatin and encloses either a single medicinal ingredient or a combination of the same. Empty capsules are available in numerous sizes depending on the dosage of medicine to be administered. The use of gelatin to make capsules is most widespread because the material renders several advantages, including but not limited to better stability in various temperature ranges, its odorlessness and tastelessness, and softness, which makes it easy to swallow. However, the market also features capsules made of other nongelatin-based materials.

The demand for empty capsules is expected to rise substantially in the years ahead thanks largely to the overall growth and expansion of the global pharmaceuticals industry. Moreover, the greater demand for nutraceuticals will also provide the global capsules market an opportunity to expand as several food supplements and functional foods are encapsulated to make them convenient for on-the-go consumption.

Global Empty Capsules Market: Trends, Drivers, and Restraints

Because capsules are regarded as a convenient method of consuming health supplements and medication, their demand is likely to grow substantially. Moreover, consumers in developing regions now have higher spending power and thus the ability to allocate more funds toward healthcare and preventative healthcare. Besides the pharmaceuticals and nutraceuticals industries, the demand for encapsulated ingredients is also on the rise in the cosmetics and cosmeceuticals sector. These end-user trends will have a far-reaching influence on the growth of the global empty capsules market.

Although there is no dearth of revenue-generation opportunities in the global empty capsules market, companies will have to brave headwinds in the form of tightening regulatory guidelines and the need for a high initial investment in R&D and manufacturing facilities. Furthermore, in mass markets such as India, where the majority of vegetarian consumers view animal-derived gelatin in a negative light, companies will face the need to find solutions around the problem by focusing more on nongelatin capsules. Overall, globally, the demand for soft gelatin capsules is showing a clear increase, and players are recommended to explore growth avenues in this space.

Request for Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1674

Global Empty Capsules Market: Region-wise Outlook

The demand for empty capsules is seen to be highest in regions where the pharmaceuticals sector is well developed. Thus, while the developed countries of the west have been the traditional markets for empty capsules, the growing number of pharmaceutical contract research establishments in Asian countries will lead to an increased demand for empty capsules.

The North America empty capsules market leads in terms of revenue share and the outlook for the Asia Pacific empty capsules market remains positive. Europe follows North America in terms of revenue in the global empty capsules market. A number of companies in the empty capsules market are increasingly moving eastward, causing a shift in the market’s dynamics.

Companies that currently rake in the highest revenue in the global empty capsules market are ACG Worldwide, Capsugel, Medi-Caps Ltd, Qualicaps, Inc., CapsCanada Corporation, Bright Pharma Caps, Inc., Suheung Co. Ltd, and Snail Pharma Industry Co. Ltd.

Operating Room Equipment Market Set to Expand by 2023

According to a new market report published by Transparency Market Research “Operating Room Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023,” the global operating room equipment market was valued at US$ 23.9 Bn in 2014 and is anticipated to expand at a CAGR of 6.9% from 2015 to 2023 to reach US$ 42.9 Bn in 2023.

An operating room, also known as operation theatre, is a facility within a hospital or nursing home where surgical procedures are performed in order to treat different physiological conditions in a sterile environment. Technological advancements have brought a lot of change in the way surgical procedures are carried out. An operating room encompasses equipment such as movable imaging systems, biomedical systems, endoscopes, anesthesia systems, operating tables, operating room lights, surgical imaging displays, operating room integration systems, surgical booms, and microscopes. The operating room equipment market studies the current as well as the future market potential for operating room (OR) equipment across the globe.

The global operating room equipment market has been extensively analyzed based on factors such as product types, technological advances, pricing, suppliers, and availability across different geographies. The market size and forecast in terms of revenue (US$ Mn) for each of these equipment categories have been provided for the period 2013 to 2023. The report also provides the compound annual growth rate (CAGR %) for the market for each segment for the forecast period from 2013 to 2023.

Significant advantages associated with operating room equipment and financial incentives by governments of various countries are the major factors driving the growth of the operating room equipment market globally. Benefits of proper operating room equipment encompasses accurate and up-to-date patient handling, enhanced patient safety, and time and long-term cost savings. These advantages encourage health care providers to equip themselves with technically advanced operating room equipment, and in turn drive the market.

Download PDF: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1674

Rapid technological advancements, need for improved efficiency, and increasing disposable income are the major factors fueling the growth of the global operating room equipment market. Advancements in patient monitoring systems include heart monitors, breath monitors, body temperature monitors, hematology monitors, multi-sign monitors, fetal and maternal monitors, oximeter, and brain monitors. The movable imaging systems segment led the operating room equipment market in 2014, due to availability of competitively priced mobile C-arms, increasing government initiatives to modernize hospitals, and increased number of surgeries propelling the market.

Key players profiled in the operating room equipment market report include Allen Medical (Hill ROM), GE Healthcare, KARL STORZ GmbH & Co. KG, Mizuho OSI, Maquet Holding B.V. & Co. KG (Getinge AB), Olympus Corporation, Philips Healthcare, Siemens Healthcare, Skytron, LLC, Steris Corporation, Stryker Corporation, and TRUMPF GmbH + Co. KG.

Global Market for Disposable Syringes

Transparency Market Research has published a new report on the global disposable syringes market. As per the report, the global disposable syringes market is expected to expand at a 5.60% CAGR during the period between 2015 and 2023. The report, titled ‘Disposable Syringes Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023,’ states that the global disposable syringes market is expected to progress from US$5.5 bn in 2014 to US$9.3 bn by 2023 due to the increasing demand for point-of-care administration and the rising use of injectable drugs.

Syringes are one of the most widely used medical products and are available in many types and sizes. The demand for disposable syringes is expected to increase in the years to come, as they continue to replace conventional and reusable glass syringes. The quality of disposable syringes is better than the conventional ones. Cost saving and use of sterilized units are two of the many benefits of using disposable syringes.

Factors such as lack of stringent government regulations and the need to meet standards that are set by the regulatory authorities are predicted to hamper the growth of the global disposable syringes market in the years to come. However, factors such as technological advancements, the increasing number of cases of needlestick injuries, and the growing variety of injectable drugs are expected to contribute towards the growth of the global disposable syringes market in the next few years.

The global disposable syringes market is widespread, with leading players covering different regions. B. Braun Melsungen AG, Becton, Dickinson & Company, CODAN Medizinische Geräte GmbH & Co. KG, Gerresheimer AG, Covidien (Medtronic plc), Retractable Technologies, Inc., Star Syringe Ltd., Smiths Medical, Terumo Corporation, and Unilife Corporation are some of the leading companies operating in the global disposable syringes market. The global disposable syringes market is segmented on the basis of geography and product type.

By geography, the global disposable syringes market is divided into Europe, Latin America, North America, Asia Pacific, and Rest of the World. Currently, the global disposable syringes market is dominated by North America, followed by Europe. The growing demand for innovative products and the rising government initiatives to promote safety mechanisms are predicted to propel the North America disposable syringes market in the near future. The increasing demand for disposable syringes is also predicted to benefit the Asia Pacific market.

Get Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1259

Based on product type, the global disposable syringes market is classified into safety syringes and conventional syringes. The safety syringes segment is sub-segmented into automatic retractable syringes, manually retractable syringes, auto-disable syringes, and non-retractable syringes. The demand for safety disposable syringes is expected to increase as they have the capacity to protect patients from accidental needlestick injuries.

Leading players in the global disposable syringes market are focusing on introducing new syringes with enhanced quality. Features such as accuracy, ease of handling, and sterility are expected to increase the demand for disposable syringes across the globe.

Medical Image Analysis Software Market - Current status and future trends

A medical image analysis software enables quantitative analysis and visualization of medical images of a range of modalities including MRI, CT, X-ray, ultrasound, PET and SPECT. The comprehensive tool for quantitative analysis and processing of biomedical images has allowed healthcare experts and surgeons to explore such images efficiently and productively. Medical image analysis software aids in the development of computational methods and algorithms in order to quantify medical data. With the development of medical image analysis software, various medical expertise have gained a lot with regards to personalized treatment and efficient data management. In addition, healthcare experts and researchers at remote sites can easily share the medical image data with the use of medical image analysis software, thereby enhancing their ability to diagnose, monitor and treat fatal diseases.

Based on imaging modalities, the medical image analysis software market has been segmented as follows:

Positron emission tomography (PET) and single photon emission computed tomography (SPECT)

• Magnetic Resonance Imaging (MRI)
• Computed tomography (CT)
• X-ray
• Ultrasound
• Microscopy

Based on end-users, the medical image analysis software market has been segmented as follows:

• General hospitals
• Diagnostic centers

Geographically, the medical image analysis software market can be segmented into four major regions: North America, Europe, Asia Pacific and Rest of the World (RoW). North America is leading themedical image analysis softwaremarket followed by Europe. The major driving factors for the growth of the medical image analysis softwaremarket in these regions arerapid technological advancement, and the growing demand for platform-independent and n-dimensional image processing and visualization. Additionally, increasing demand for diagnostic procedures globally with continuous innovative development and reliable support is expected to drive the market growth during the forecast period. Hence, all these factors are collectively driving the demand for medical image analysis software. However, certain factors such as limited knowledge of people in terms of software usage, and expensive nature of such medical software can pose to be a major hindrance in the growth of medical image analysis software market in developed regions.

Get a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5306

Asia Pacific is one of the most profitable markets for the growth of medical image analysis software market and is developing at a sharp rate. The factors which will augment the growth of this market in Asia Pacific are increasing incidences of diseases which require diagnostic tools, coupled with greater amount of patient data. Furthermore, development of natural user interfaces for medical practitioners in order to achieve better diagnostic platform is also anticipated to boost the growth of medical image analysis software market in Asia Pacific. Economic development, improving healthcare facilities,rising disposable incomes and government initiatives provide a large base of patient population with access to healthcare facilities at an affordable rate, hence driving the developing countries market growth.

Various manufacturers of medical software companies are launching novel technological platformto effectively cater to the diagnostic procedures. Technological innovation and advancements among a range of medical image analysis software is one of the most significant aspects for the manufacture of such medical software. Some of the top major players operating in the medical image analysis software market are GE Healthcare, Philips, Agfa Healthcare, Spacelabs Healthcare, EsaoteSpA, Xinapse Systems Ltd., Claron Technologies, Siemens AG, Toshiba Medical Systems, and others.

Electrical Stimulation Devices Market Dynamics and Opportunities Report by Transparency Market Research

Electrical stimulation devices or electronic muscle stimulation devices are essentially electrotherapy devices that are specifically designed to cause muscle contraction via electrical impulses. Non-invasive technology devices have been a major focus area in the past few years of medical device manufacturers, as majority of ESDs available in the market require surgical implantation as well as replacement surgeries after every few years. Factors such as escalating prevalence of chronic medical conditions, increasing geriatric population, introduction of novel technologies are driving the growth of the global electrical stimulation devices market. However, certain factors such as presence of alternative treatment therapies, low endorsement from regulatory bodies, and risks associated with implant procedures might pull back the growth of electrical stimulation devices market.

Based on device type, the global electrical stimulation devices market has been segmented into spinal cord stimulation (SCS) devices, deep brain stimulation (DBS) devices, vagus nerve stimulation (VNS) devices, sacral nerve stimulation (SNS) devices, gastric electric stimulation (GES) devices, transcutaneous electrical nerve stimulation (TENS) devices, neuromuscular electrical stimulation (NMES/EMS) devices, and other electrical stimulation devices (electrotherapy devices, combination devices, TNS, TMS, etc.). Spinal cord stimulation (SCS) devices dominated the market in 2014 due to increasing number of SCS implantation in the chronic pain management of trunk or limbs, which includes pain associated with post-back surgery syndrome, lower back, or legs coupled with growing incidence of neuromuscular diseases in developed regions. However, the vagus nerve stimulation (VNS) devices segment is expected to grow at the highest CAGR during the forecast period as these devices are becoming extremely important to reduce epilepsy seizures and improve postictal recovery in patients.

The application segment in the electrical stimulation devices market has been categorized into pain management, neurological and movement disorder management, musculoskeletal disorders management, metabolism & GIT management (stomach, intestine, pancreas, digestion, blood pressure, nausea, vomiting, gastroparesis, etc.), incontinence management (fecal incontinence, urinary incontinence, urinary retention), and others (aesthetics, training, cosmetics, etc.). Pain management was observed as the largest segment in terms of revenue in 2014. Increasing incidence of chronic pain and other pain among the population and clinical studies supporting the benefits of ESDs boost the usage of these devices in the pain management segment. However, neurological and movement disorder management segment is expected to expand at the highest CAGR during the forecast period due to the increasing incidence of psychiatric disorders such as Parkinson’s disease among population and growing applicability of neural stimulators in various neurological disorders.

Get a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=7075

Geographically, North America accounted for the largest share of the global electrical stimulation devices market in 2014. Factors attributed to the dominant position of North America in electrical stimulation devices market are growing prevalence of lifestyle-related diseases, increasing number of sports related injuries, increased access to health care, and rising incidence of pain indications among geriatric. However, Asia Pacific is anticipated to witness the highest growth during the forecast period. Key factors such as phenomenally increasing base of aging patient population, increasing disposable income among population in various emerging economies, and greater demand for advanced medical interventions would accentuate the growth of electrical stimulation devices market in Asia Pacific. China is the major market for electrical stimulation devices in Asia Pacific. Factors such as large geriatric population, significant rise in health care spending, large population of disabled people, increase in chronic illnesses, high incidence rate of traffic accidents would boost the growth of the ESDs market in China.

The global electrical stimulation devices market is highly competitive and oligopolistic. The prominent companies governing the electrical stimulation devices market are Boston Scientific Corporation, BTL Industries, Inc., Cyberonics, Inc., DJO Global, EnteroMedics Inc., Medtronic plc, Nevro Corp., NeuroMetrix, Inc., St. Jude Medical, Inc., Uroplasty, Inc. (Cogentix Medical), and Zynex, Inc. Easy commercial availability of products, superior distribution channels, and ample supply capabilities are the other major factors that play an important role in determining the market position of these players.

Leading Players in European Molecular Diagnostic Market

According to a new market report published by Transparency Market Research “Molecular Diagnostic Market for Group A Streptococcus (GAS) Nucleic Acid (NA) Test Products Market - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2015 - 2023”, the Europe molecular diagnostic market for group A streptococcus (GAS) nucleic acid (NA) test products market was valued at US$ 8.3 Mn in 2014 and is projected to expand at a CAGR of 11.6% from 2015 to 2023 to reach US$ 22.3 Mn in 2023.

Rapid and accurate diagnosis is a key factor for effective disease treatment. Increasing incidence of Streptococcus pyogenes infection in Europe, advancement of technology, and rising demand for point-of-care testing act as a high impact drivers of the market. Advancements in techniques such as isothermal nucleic acid amplification tests is likely to propel the market during the forecast period. The molecular diagnostic market for group A streptococcus (GAS) nucleic acid (NA) test in Europe has been segmented based on type of test technique, end-user, and region.

A study conducted by the American Society for Microbiology concluded that incidence rate of Streptococcus pyogenes is high in countries in Northern Europe. The incidence of the disease has increased at a steady rate in most of these countries of the market. The automated detection system offers a faster, more flexible, and cost-effective solution to clinicians. Advancement of technology is bringing testing services to point-of-care. Due to its high sensitivity and accuracy the tests are backs up all negative rapid antigen assays. The Advancements in nucleic acid testing technologies and their adoption in Europe would result in high growth adoption of the technology will primarily occur in the developed countries. Ineffectiveness and slow adoption are the major restraints of the market.

The polymerase chain reaction segment held the largest share of the market in 2014, followed by the non-amplified tests segment. PCR is a traditional technology used for nucleic acid tests. However, the new, efficient, and user-friendly methods, such as isothermal nucleic acid amplification and non-amplified tests, are likely to capture higher market share in the near future. Isothermal nucleic acid amplification technology has been identified as the fastest growing segment during the forecast period due to its accuracy and rapid identification. Nucleic acid amplification techniques take tiny amounts of DNA or RNA, replicate them many times, and thus can detect minute traces of an organism in a specimen, avoiding the need for culture. Non-amplified technology using hybridization probe would capture a decent share in the market during the forecast period.

The hospitals end-user segment accounted for over 58.2% share of the nucleic acid (NA) test products market in Europe in terms of revenue in 2014, followed by the public health laboratories segment. Moreover, the segment is expected to gain market share and emerge as the fastest growing segment during the forecast period.

Western Europe was the largest market for nucleic acid (NA) test products in 2014, accounting for around 48.9% share. Western Europe dominated the market due to highly developed health care infrastructure and favorable reimbursement scenario. On the other hand, Northern Europe is expected to gain high market share during the forecast period owing to increase in incidence of Streptococcus pyogenes infection and high adoption rate.

Get a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=10505

Alere, Inc., F. Hoffmann-La Roche Ltd., Hologic, Inc., Meridian Bioscience, Inc., Nanosphere, Inc., and Quidel Corporation are the major players operating in European Molecular Diagnostic Market for Group A Streptococcus (GAS) Nucleic Acid (NA) Test Products market.

Predictions for Pressure Relief Devices Market in the next decade

Pressure ulcers, commonly known as bedsores, are localized injuries to the skin that typically occur on a bony prominence due to pressure or friction on the skin. Pressure ulcers are usually prevented by a number of support surface devices such as mattresses, cushions, overlays, and specialty beds. Tissues and skin being compressed directly between the bone and support devices such as mattresses, beds, and wheelchair increases pressure on the affected area of the body.

Thus, in order to overcome this problem, advanced global pressure relief devices market such as gel-filled mattresses, foam-filled mattresses, and air-filled mattresses are designed and sold in the market to reduce pressure in the body and improve the quality of life of patients.

What is Driving Demand from Global Pressure Relief Devices Market for Treating Pressure Ulcers?

The increasing prevalence of pressure ulcers among the global population is the main factor highlighting the need for pressure relief devices across various regions. Besides the rising awareness about pressure ulcers in patients, rise of common diseases such as depression, paralysis, arthritis, and polymyalgia are the main causes of immobility in patients. Old age is one of the main causes of immobility and high blood pressure. Hence, the increasing global geriatric and obese populations are the prime factor highlighting the need for pressure relief devices and driving the market.

Due to all the aforementioned growth factors, the pressure relief devices market is expected to reach a market value of US$2.8 billion by 2020 from a value of US$2.0 billion in 2013, states Transparency Market Research in its latest report. The firm estimates the market will grow at a CAGR of 5.2% between 2014 and 2020 forecast period.

Pressure relief devices are recognized as essential safety measures for high-pressure gas storage and distribution systems. They are typically used as a means of venting excess pressure, which could rupture a pressure vessel in the body. These devices are viewed as emergency or safety devices in times when other safety devices fail to operate in a medical emergency situation. The primary purpose of pressure relief devices is protection of life by redirecting excess pressure or fluids from an over-pressurized vessel in the body.

Download PDF: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1743

North America Expected to Continue Leading Global Market for the Next Five Years

North America held the largest share of the global pressure relief devices market in 2013. Rise in geriatric population and established reimbursement policies in this region are some of the primary growth factors supporting the pressure relief devices market in North America. According to the Agency for Healthcare Research and Quality (AHRQ), more than 2 million people in the U.S. are diagnosed with pressure ulcers every year. Hence, the increasing prevalence of pressure ulcers and rising awareness for suitable treatments are further highlighting the need for effective devices such as the pressure relief devices in the global market.

Nowadays, the demand for various advanced mattresses is also growing among North Americans. Such factors are further expected to continue to stimulate the pressure relief devices market until 2019.

A brief review of Personalized Medicines Market

Personalized medicine is a concept that has the potential to transform medical interventions by providing effective and tailored therapies. The development of personalized medicine is a novel approach to introduce new dimension in medicine and healthcare industries. It includes the use of molecular analysis to achieve optimal medical outcome in management or diagnosis of patient’s disease. The main objective of personalized medicine is to identify most appropriate treatment option for patient population.

The market of personalized medicines and pharmacodiagnostics can be segmented as below:

• By Therapeutics
  • Cancer Management
    • Tissue-based Tests
    • Blood Markers
    • Circulating Tumor Cells
  • Infectious Diseases
    • HIV
    • HBV
    • HCV
  • Hospital Acquired Infections
  • Coagulation Therapy
  • Autoimmune Diseases
  • Cardiovascular Diseases
  • CNS Disorders
  • Diabetes
  • Blood Transfusion Safety
• By Diagnostics
• By Theranostics
• By Application
  • Pharmaceutical
  • Diagnostics
  • Healthcare
• Others

The market of personalized medicine is witnessing positive growth owing to the advancement in technologies coupled with introduction of new technologies by key players. For example, in June 2013, Natural Molecular Testing Corporation launched expanded cardiac personalized medicine based on Luminex Corporation’s xMAP technology. In addition, introduction of technologies like NanoVelcro chip devices and gene therapies by using pill for treating cancer will increase the customer base for personalized medicines and hence stimulates the market growth. Furthermore, personalized medicines have increased the possibility of healthcare profits, safety of patients and improve the clinical results which will further drive the growth of the market of pharmacodiagnostics and personalized medicines. For example, personalized medicines offer cost-effective treatment and also eliminate overspending for the cancer treatment. This factor would ultimately attract more number of customers to use personalized medicines and hence drives the market growth. Moreover, various other factors like early diagnosis of diseases, high adverse reaction of prescription drugs, changing patient’s trend and patient compliance would also augment the market growth. Furthermore, personalized medicines have major impact on small to medium sized enterprises (SMEs). It offers great business opportunities for these companies to develop their industrial boundaries across the globe. Thus, all the above mentioned factors would increase the use of personalized medicines by SMEs and hence further augments the market growth. However, implementation of personalized medicines in biomedical research and in clinical applications is still at a low pace which might restrict the growth of this market.

Get a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=394

Geographically, North America dominates the global personalized medicines market. Advancement in technologies and increasing research activities on human DNA by various biotechnology companies in North America will drive the market growth. In addition, increasing incidence and prevalence of cancer and cardiovascular diseases in North America further drives the market growth. Europe is considered as the second largest market of personalized medicines. The growth of personalized medicines market in Europe is mainly attributed to consistent efforts of private research institutes and government for the development of clinical application for cancer, heart diseases and neurodegenerative disorders. Asia-Pacific region is considered as an emerging market for personalized medicines owing to ability of personalized medicines to provide cost effective and safer treatment options.

The leading players competing in personalized medicines market are Bayer HealthCare Pharmaceuticals, Abbott Molecular, Inc., Celera Diagnostics, Hologic, Inc., Rosetta Genomics Ltd., Macrogen, Inc., IRIS Personalized Medicine, Bristol-Myers Squibb, Cepheid, Curagen Corp., Decode Genetics, Exagen Diagnostics, Dako Denmark A/S, Exact Sciences Corp. and others.

Growing Trends in Enteric Disease Testing Market

Transparency Market Research has published a new report on the global enteric disease testing market. According to the report, the global enteric disease testing market is expected to progress from US$3.1 bn in 2012 to US$3.6 bn by 2019. The report, titled ‘Enteric Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,’ states that the global enteric disease testing market is expected to expand at a 2.40% CAGR during the period between 2013 and 2019 due to factors such as the increasing demand for rapid diagnosis, the untapped market in developing nations, and the increasing application of molecular diagnostics.

Enteric diseases or gastrointestinal infections are caused by a range of microbes comprising bacteria, parasites, and viruses, primarily when they enter the body via the mouth. Numerous microbes responsible for enteric diseases are salmonella, rotavirus, C. difficile, vibrio, campylobacter, shigella, and norovirus. These diseases may have mild or severe symptoms including bloody diarrhea, stool containing blood or pus, weight loss, fever, and abdominal cramps. To reduce the complications, enteric diseases have to be diagnosed early.

The global enteric disease testing market is segmented on the basis of geography and type of disease. Based on geography, the global enteric disease testing market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2012, in terms of growth and potential, Asia Pacific accounted for more than 50% of the global enteric disease testing market. Factors such as the rising awareness, high occurrence of enteric diseases, and the inception of quick diagnostic tests are expected to propel the Asia Pacific enteric disease testing market in the next few years. The high level of consumer awareness is expected to propel the North America enteric disease testing market in the years to come. Some of the leading players in the global enteric disease testing market are DiaSorin, Alere, Meridian Bioscience, Cepheid, and Biomerica.

By type of disease, the global enteric disease testing market is classified into bacterial enteric disease testing, viral enteric disease testing, and parasitic enteric disease testing. The bacterial enteric disease testing segment is sub-segmented into C. difficile infection, cholera, E. coli infection, campylobacteriosis, and others. Earlier, the diagnosis of enteric diseases depended on culture results of stool samples. However, today, the trend is shifting towards other diagnostic methods due to the many limitations connected with culture tests. High cost and the requirement for sophisticated laboratory equipment, labor, and skilled personnel are some of the drawbacks related to culture tests. In many developed regions, PCR-based diagnostic procedures are recommended to test enteric diseases as they offer high specificity and sensitivity and are rapid, accurate, and easy to manage.

Get a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1258

The global enteric disease testing market is expected to be hampered by factors such as the growing occurrence of mild and asymptomatic diseases and lack of awareness. However, the global enteric disease testing market is expected to register considerable growth due to the rising opportunities in molecular-diagnostics-based enteric disease testing and the growing opportunities in developing nations.

Hyaluronic Acid Market to Register Impressive CAGR, Driven by Increasing Demand for Anti-Aging Procedures

Hyaluronic acid is a crucial part of the human skin and has a beneficial effect on the durability of skin. It is also called hyaluronan or hyaluronate and is naturally present in connective, neural, and epithelial tissues. The production of hyaluronic acid slows down with aging, aiding the degradation of skin cells. The rising awareness about this natural process has led to high demand for hyaluronic acid products of various types. According to Transparency Market Research, the global hyaluronic acid products market is expected to rise to a valuation of US$9.8 bn by 2019.

Here are the primary driving factors propelling the global hyaluronic acid products market:

Increasing Demand for Anti-aging Products: The global population is keener than ever to maintain a youthful appearance, leading to steady demand for various skincare products. The rising usage of hyaluronic acid, due to its biocompatibility, has resulted in high demand from the global hyaluronic acid products market.

Rising Awareness Regarding Risks of Synthetic Skincare Products: The USP of hyaluronic acid has always been the fact that it is not only naturally found but also naturally produced within the human body. This renders it safe for skincare applications. Since most artificial skincare compounds can have adverse effects on the skin, the usage of hyaluronic acid products is on the rise, boosting the global market.

High Demand for Minimally Invasive Procedures: The convenience of hyaluronic acid products, which are just as effective when applied topically as when injected into the body, is another major factor propelling the global hyaluronic acid products market. Instead of injections of compounds boosting the appearance of skin, such as botox, the usage of hyaluronic acid products to boost the internal system maintaining the health of skin is rising.

Request for Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2033

Rising Living Standards in Asia Pacific to Boost Global Hyaluronic Acid Products Market

The regional market for hyaluronic acid products in Asia Pacific was the third largest regional segment of the global hyaluronic acid products market. This region, however, is expected to be the fastest growing market for hyaluronic acid products in the coming years. Along with other developing countries in Rest of the World, Asia Pacific countries are expected to witness high rates of development of medical infrastructure in the coming years. This will directly propel the global hyaluronic acid products market, as treatments involving hyaluronic acid products will be more accessible to the common man.

In addition to this, the rising living standards in dynamic countries such as India, China, Thailand, Singapore, etc. will also benefit the hyaluronic acid products market. The increasing awareness about and demand for maintaining a youthful appearance as a result of the increased living standards will propel the Asia Pacific hyaluronic acid products market at a steady pace in the coming years.

Viscosupplementation Market - Current status and future trends

Viscosupplementation is a minimally invasive procedure that involves injection of gel-like substances into a joint to assist the viscous properties of synovial fluid. As of now hyaluronate injections are only approved viscosupplementation treatment of osteoarthritis of the knee. Hyaluronic acid (HA) or hyaluronate is a non-sulfated glycosaminoglycan that is distributed throughout the body in epithelial, connective tissues, and neural tissues. Hyaluronic acid is observed to be an integral component of the extracellular matrix as it contributes significantly to migration and cell proliferation. Hyaluronic acid acts as a joint lubricant and elastic in nature that allows it to act as a shock absorber because of its viscous nature. Chemical modification allows Hyaluronic acid to transform into several physical forms such as soft or stiff hydrogels, non-woven meshes, flexible sheets, viscoelastic solutions, electrospun fibers, macroporous, fibrillar sponges, and nanoparticulate fluids for use in a range of preclinical and clinical applications. According to the WHO, osteoarthritis is a degenerative joint disease that mainly affects the articular cartilage and is related with aging. This condition affects the joints that have been continually stressed over the years including the hips, fingers, lower spine and knees. According to the WHO, globally, around 9.6% men and 18.0% women are above the age of 60 years and suffer from symptomatic osteoarthritis, which is one of the top disabling diseases in developed countries. Osteoarthritis is mostly classified in two types: primary and secondary where primary osteoarthritis occurs due to aging and wear and tear of joints and secondary osteoarthritis occurs due to an accident or obesity at an early stage.

Factors driving the growth of viscosupplementation market are increasing geriatric population, increasing demand for minimally invasive surgical procedures, high patient awareness about new drugs and devices for the treatment of osteoarthritis and rising obese population globally. However, lack of safety and inefficiency of the products might hamper the market growth. The product innovation and process development is an opportunity window for market players as safety and efficacy are the major concerns of viscosupplementation products. Thus, introduction of products that helps to overcome these concerns have an opportunity to enter and establish in the global viscosupplementation market.

The FDA approved hyaluronates currently available in the viscosupplementation market are Hyalgan (Sanofi), Euflexxa (Ferring Pharmaceuticals, Inc.), Orthovisc (Anika Therapeutics), Supartz and Gel-One (Seikagaku Corporation), and Synvisc, Synvisc One (Genzyme) and Durolane (Q MED AB).

Download PDF: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=10232

North America is the largest viscosupplementation market globally accounting for high product demand, high awareness in the region and acceptance of high priced products. Europe experienced an economic downturn that created problem in the hyaluronic acid products market as reimbursement policies turned out to be difficult but still the premium priced products were accepted in some of the countries. Although European market is expected to review and provide essential opportunity for viscosupplementation products as the economical conditions are reviving. Asia-Pacific and RoW observed to be the emerging markets for viscosupplementation and Asia-Pacific viscosupplementation market is especially driven by economic development, healthcare facility enhancements and high demand for minimally invasive surgeries.

Some of the key players of viscosupplementation market are Alcon, Inc., F. Hoffmann-La Roche Ltd., Allergan, Inc., Fidia Farmaceutici SpA, Anika Therapeutics, Inc., Ferring Pharmaceuticals, Inc., GALDERMA S.A., LifeCore Biomedical LLC, Hyaltech Ltd. and others.

Computed Tomography Market To See Good Times Ahead

Transparency Market Research has published a new market study on the global computed tomography (CT) market that delves into developments in the said market from 2011 to 2017. According to the report’s findings, the market will display a CAGR of 4.5% between 2011 and 2017, resulting in the market’s valuation increasing from US$4.3 bn in 2011 to US$5.6 bn by 2017. The report is titled “Computed Tomography (CT) Market: Global Industry Analysis, Size, Share & Forecast (2010 - 2017)” and is available for sale on the company’s website.

The report looks into developments in the market from the perspectives of market indicators, the latest trends, growth opportunities, and competitive hierarchy across North America, Asia Pacific, Europe, and Rest of the World for the 2011-2017 period. The report is prepared using standard research methodologies and validated analytical tools such as Porter’s five forces analysis and SWOT analysis to ascertain an accurate trajectory of the market’s growth during the forecast period.

Computed tomography is a diagnostic imaging tool that produces detailed pictures of internal organs, soft tissues, bones, and blood vessels. It uses special X-ray equipment to create cross-sectional images of distinct areas of scanned objects, which can be reformatted in two-dimensional or even three-dimensional planes.

The report cites several reasons for the growth of the global CT market. An increasing pool of the ageing population and an increasing patient pool with chronic diseases are the foremost reasons for growth of the CT market. In particular, Asia Pacific is exhibiting a rise in its geriatric population, thereby displaying an increasing demand for modern diagnostics.

The report segments the global CT market on the basis of two criteria, namely product type and region. According to product type, the segments of this market are low-end slice CT, high-end slice CT, and mid-end slice CT. Amongst all, high-end slice CT is expected to gather a major chunk of the revenue, estimated at about 55.9% by the end of 2017. In absolute numbers, this equals US$3.1 bn.

Geographically, North America is currently the leading market for CT. The region being traditionally technologically advanced and home to a significant health-conscious aging population are the reasons for this. However, during the forecast period, Asia Pacific is expected to exhibit the fastest growth in comparison to other regional markets for computed tomography. This is due to the rising awareness among individuals about modern diagnostics, improved financial state, and the emergence of modern healthcare facilities in this region.

Get a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=227

In other developing regions, increasing disposable incomes and increasing awareness about the importance of timely diagnosis of chronic diseases are the major factors driving the computed tomography market. These factors are further augmented by the declining cost of equipment and increasing accuracy due to consistent technological advancements in the CT industry.

The report mentions and profiles top players in the global computed tomography market, which are GE, Toshiba, Siemens, and Phillips. These companies have been profiled for attributes of product portfolio and specification, financial standing, business positioning, and SWOTs.